0YUC47Z
Supplement Upper Leg, Right to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | Y Anatomical Regions, Lower Extremities |
| Operation | U Supplement |
| Body Part | C Upper Leg, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in this family involve placing biological or synthetic material into or onto a lower extremity anatomical region to physically reinforce or add bulk to existing tissue, rather than to replace missing structure. Surgical mesh used to reinforce weakened fascia or a defect in the leg or foot region, or an autologous or donor graft layered onto tissue to strengthen it, are typical examples.
This type of procedure is chosen when the body part is present and largely intact but needs additional support to hold its shape, resist strain, or heal properly, such as reinforcing a soft-tissue closure after trauma or a prior surgical repair. It differs from simply closing or repairing a wound because material is deliberately added to bolster the area beyond what the patient's own tissue can currently provide.
Anatomy & Axis Detail
Upper Leg, Right
The right upper leg, extending from the hip crease to the knee, is supplemented when the thigh's fascia, muscle investment, or overlying soft tissue needs physical reinforcement without removal of the native structure, as seen after muscle flap donor site closure, chronic wound management, or repair of fascial dehiscence following prior thigh surgery. The large muscle mass and substantial subcutaneous tissue of the thigh generally provide a favorable bed for graft incorporation, but the sciatic and femoral neurovascular bundles running through the region require careful surgical planning to avoid impingement from reinforcing material. Surgeons choose between autologous grafts, allografts, or synthetic mesh depending on the defect's size and contamination risk, and this choice determines the specific device value used in coding. Prior orthopedic hardware or vascular repairs in the thigh are relevant surgical history.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
A coder assigns Supplement when documentation shows material was added to reinforce or augment a body part that remains present, with the graft or mesh serving a support function rather than substituting for an absent structure. The note should specify the material used, whether autograft, allograft, or synthetic mesh, since device and substance qualifiers affect code selection. A common error is coding Supplement when the material is actually replacing a resected or absent structure, which belongs to Replacement instead, or coding Repair when reinforcing material was in fact placed, which should be captured as Supplement.